Metformin reduces the competitive advantage of Dnmt3aR878H HSPCsMohsen Hosseini, Steven M. Chan, Vivian Wang et al.|Nature|2025Cited by 43
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Samuele Ferrari, Martina Fiumara et al.|Nature Medicine|2025Cited by 38
Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateSteven M. Chan, Jennifer J. Trowbridge, Mohsen Hosseini et al.|Research Square|2024Cited by 5
Poisoning of Healthy Hematopoiesis Is an Unanticipated Mechanism Driving Clonal Dominance in Vexas SyndromeMartina Fiumara, Samuele Ferrari, Raffaella Molteni et al.|Blood|2024Cited by 1